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ABSTRACT
Nervous System cancer age-specific mortality rates began being recorded for European
and Non-European Americans in 1930 and for Japanese in 1952. All ethnic groups show
significant historical increases in mortality rates. For the two American data sets, the
age-specific pattern for mortality seems to have stabilized starting with the birth cohort of
the decade of the 1900s. For the Japanese data set, the pattern stabilizes starting with the
birth cohorts of the 1910s and 1920s. These stabilized patterns of NS cancer incidence
are similar to the age-specific mortality rates for many other cancers. That is, the rates
are higher in the first five years of life then in the next five years, then the rates rise
rapidly above the neonatal rate until the age of maturity. During maturity, the rate
increases as a constant exponential function and reaches a maximum at around the ages
80-85 years old. Changes in cancer incidence can only be caused by two factors,
environmental and genetic effects. Given the suddenness of the change in NS cancer
mortality rates, we can rule out the contribution of a possible genetic effect and focus on
characterizing a possible environmental risk factor. Herein the possibility of
electromagnetic waves from power-grid systems increasing risk for NS cancer is
considered, and using the data and historical evidence this possibility is ruled out. In
order to understand the relationship between the molecular mechanisms of mutagenesis
and the incidence of cancer, a physiologically based quantitative model which includes
the processes of mutation, cell proliferation and death. We use the two-stage model of
cancer of Armitage and Doll (1957), whereby the first stage is initiation, where "n"
events occur to create the first preneoplastic cell which grows slowly at the juvenile rate.
The second stage takes place when a preneoplastic cell experiences "m" events which
lead to promotion, after which the neoplastic cell will grow rapidly as a tumor. This
model has been adjusted by Moolgavkar and Knudson (1981) and Herrero-Jimenez et al.
(2000) to take into account cell growth rate and human heterogeneity respectively. This
model is applied to the birth cohort of 1920 in order to demonstrate how we can calculate
the fraction of the population at primary risk for NS cancer, and how this has changed
over time.
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Chapter 1: History of Nervous System Cancer in male and female
European and African Americans and Japanese
For cancers of the nervous system, including eye cancer, there is a trend across the
decades of 1900 to 1980 where incidence is relatively high in infancy, then sharply
declines, then begins to rise at the age of 20 years and continues to do so until there is a
maximum plateau around 80-85 years of age. The overall trend has been an increase in
incidence of NS cancer over the past century, not unlike the trends with many other
cancers of organs, such as lung cancer.
Materials and Methods
Data
Specific cancer mortality data was obtained from MIT's epidemiology database page
(epidemiology.mit.edu). Dr. Herrero-Jimenez assembled the database and matched the
mortality statistics with population figures. Cancer mortality statistics were first recorded
in 1900 in the US and 1952 in Japan. For NS cancer, mortality statistics were recorded
starting in 1930 in the US. The raw US data is obtained from the Department of Health
and Human Services (1937-1997) and the US Bureau of the Census (1930-1936). Age-
specific population statistics since 1950 were retrieved from the Duke University Center
for Demographic Studies. Japanese data was obtained from the University of Tokyo's
Department of Public Health. In the analysis of NS cancer, namely brain cancer, the
assumption is made that mortality is a good indicator of incidence, given the lethalness of
the disease.
Certain confounding factors include the accuracy of the mortality and population records
compiled by the US government. Another factor is the misdiagnosis of brain cancer.
Cancers of other organs can metastasize into the brain, which might mislead the health
official into incorrectly labeling the disease NS cancer.' Conversely, brain tumors rarely
metastasize to other organs. Another confounding variable is the historical changes in
autopsy frequency. Autopsy rates in the US rose during the period of the 1930s to 1960s;
however, since then they have decreased back to the 1930s levels.
1 Inskip PD, Linet MS, Heineman EF. Etiology of brain tumors in adults. Epidemiol Rev 17:382-414(1995).
Methodology
The data is organized in six different groups: European American males and females,
Non-European males and females (of whom 80-90% were of African descent), and
Japanese males and females. The number of deaths and population numbers were
organized by birth decade cohorts, meanwhile age of death was organized in five year
intervals (0-4yrs, 5-9, etc.). The age of death is defined at t, and the birth cohorts are
defined by h. Using these data, we can define the function OBS(h,t), following the
method of Herrero-Jimenez et al.2, as:
OBS(h,t) = observed number dead due to NS cancer of birth cohort h and age interval t
population of birth cohort h live in age interval t
Herrero-Jimenez have further refined this model to more accurately reflect the risk of
getting and dying from a certain cancer. Medical technology has certainly improved over
the past century which affects the survival rate given a diagnosis of a certain cancer. For
instance, if a certain cancer once was untreatable but is now completely treatable, then
deaths caused by this cancer would not be a good measure for incidence. Thus, to the
model was added the parameter SUR(h,t), the probability of surviving for five years post
diagnosis. For NS cancer, unfortunately we still are unable to cure most cases, and
therefore the five-year survival rate is essentially zero. Additionally, the accuracy of
diagnoses of certain cancers could also change over time given advances in medical
technology. Thus the parameter REP(h,t) was added, which is the probability of an
accurate recording derived from the fraction of deaths reported from uninterpretable
causes. By 1930, when our US data begins, REP(h,t) was already approximately 1,
including the mortality of the extremely aged. Lastly, OBS(h,t) would underestimate the
incidence and risk of getting a specific cancer because it does not take into account
competing forms of death. That is, a person who has died from one disease would
possibly have been at risk for another, had he not died. To address this, the term
TOT(h, t) was introduced, which represents the death rate from all possible causes for a
birth cohort h and age t. Therefore, the adjusted OBS(h, t) is defined as:
OBS*(h, t) = OBS(h, t)/[(1-SUR(h, t))(REP(h, t)(1-TOT(h, t)+OBS(h, t))]
As mentioned above, SUR(h, t) for NS cancer can be approximated as zero, and REP(h, t)
is essentially one. Since NS cancer mortality is a very small portion of total deaths, i.e.
OBS(h,t) << TOT(h,t), we can approximate the adjusted function as:
OBS*(h,t) = OBS(h,t)/(1-TOT(h,t)).
2 Herrero-Jimenez, P., Thilly, G. et al. Mutation, cell kinetics, and subpopulations at risk for colon cancer in
the United States. Mutat Res 400:553-378 (1998).
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Figure 1: NS Cancer Age-Specific Mortality Rates in European American Males
(1930-1997)
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Figure 1 shows OBS(h,t) for European American Males. The same figures for the
remaining data groups can be found in the appendix.
European American Males and Females
For European-American males (EAM), for birth cohorts up to the 1860s, there is a
significant increase in incidence from the ages of 80 years to 90 years old. From the birth
cohorts of the 1870s and onward, there is a steady increase in OBS until slightly before
80 years old when the rate begins to plateau.
Also interesting is the fact that the curves from the cohorts of 1900s onward are almost
identical, especially after the juvenile period. The OBS rates seemed to be increasing
consistently until the birth cohorts of 1890s and 1900s. For example, a 75 year old born
in any decade in the 20th century is about 10 times more likely to die from NS cancer than
a person the same age born in the 1860s, only 40 years prior.
In the stabilized cohorts, i.e. 1900s and beyond, the age at which the maximum rate
occurs seems to be 80-85.
The data for EAF mirrors those for EAM in shape, but is slightly smaller in magnitude.
Non-European American Males and Females
NEAM and NEAF curves follow the same patterns as EAM and EAF, showing a general
increase in OBS until the birth cohorts of 1900s and onwards when the incidence
stabilizes. While the shapes of the curves are similar to those of EAM and EAF, the
magnitude of NEAM is less than EAM and EAF, and the magnitude of the NEAF curves
is even lower.
Japanese Males and Females
In JM and JF curves, one can see a similar increase in OBS over time, with two
interesting differences from the US data. First, the pattern does not stabilize until the
birth cohorts of 1910s and 1920s, which is 10-20 years after the curves stabilized for the
American cohorts. The second important difference is that the magnitude of the Japanese
OBS curves is much smaller than the analogous American curves. These two differences
are consistent with observations from other cancer types.
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Figure 2: NS Cancer Age-Specific Mortality Rates for European American Males as
a Function of Calendar Year of Death
Figure 2 shows the function OBS(h,y) where y = h + t, for European American males.
This allows us to see mortality rates as a function of the calendar year of death. The
analogous graphs for the other data groups can be found in the appendix. The advantage
of this graph over the plot on the age scale is that it allows us to distinguish those curves
which were very similar on the age scale. That is, the birth cohorts of 1900s and onward
were almost identical in Figure 1. Here, we can see that these curves do in fact have the
same shape and magnitude (i.e. same age-specific mortality rates) but they are shifted
according to the calendar year. Whatever the environmental factor was that caused the
change in NS cancer incidence for EAM, Figure 2 indicates that it did not occur during or
after the lifetime of the 1900s birth cohort. Thus, we can deduce that the environmental
factor started taking into effect sometime in the latter half of the 1800s in America for
European and Non-European Americans. In Japan, the environmental factor seems to
have taken into effect 10-20 years after it did so in the US. Lastly, given that the birth
cohorts before stabilization (i.e. before the 1900s cohort for Americans and 1910s/1920s
cohort for Japanese) showed no consistency, the environmental factor was probably
acting over a long period of time which caused a continual change from the birth cohorts
of 1850s to 1900s.
There are other cancers which seem to follow similar, but not identical, patterns. For
instance, lung cancer OBS(h,t) rises with age and reaches a maximum at the age interval
of 80-85. There is also a shift due to an environmental factor but the rates stabilize
beginning with the birth cohort of 1890s and 1900s. Another similarity between lung
cancer and brain cancer arises when you compare the American and Japanese data. Just
as with NS cancer, the environmental factor affecting Japanese lung cancer incidence
seems to take into effect 10-20 years later than for America. This may imply that one
environmental factor such as smoking cigarettes contributed to the shift in incidence of
both lung and brain cancer. Chapter 2 addresses the assessment of a possible
environmental risk factor.
Chapter 2: History of the Hypothetical Risk Factor
The figures and analysis in Chapter 1 show that there has been a clear rise in the rate of
NS cancer. Most research done recently to discern what environmental factors can
increase risk of NS cancer have been case-control studies on a small scale, such as
workers in a factory or residents in a town where possible clusters of incidence exist.
However, clearly there has been a shift that put a significant portion of the population at
higher risk. Acknowledging this leads one to search for a more universal environmental
factor to which a significant portion of the population was exposed. Here I demonstrate
how to assess a hypothetical risk factor by looking at the appearance of extremely low
frequency electromagnetic waves from power lines in American society.
History of American Electric Power Transmission
In 1888 Nikola Tesla introduced the concept of using alternating currents in motors and
transformers, paving the way for the development of power line systems. Scientists
could now expand upon the already existing electric utility systems and deliver power to
homes miles away. In 1907, only 8% of American homes had electricity. By 1932, this
figure rose to 67%, however, only 11% of farm dwellings were electrified, compared to
well-over 80% for urban settings.3
In an attempt to address this concern, the Federal Government passed the Rural
Electrification Act in 1936. By 1941, 35% of rural homes were electrified. As
technologies improved and demand increased (especially during World War II), so did
the amount and breadth of electricity consumption. By 1945, half the farm homes in
America were connected to an electric grid, and by 1950, this figure reached 80%. 4
Health Concerns with Extremely Low Frequency Electromagnetic Waves
Although by the midway point of the past century power lines were ubiquitous in
America, concerns about the possible carcinogenic effects of EMFs at extremely low
frequency (60 Hz) from these power lines did not rise until a landmark study done in
Colorado was published in 1979. 5 The case-control study examined homes which lived
close to power lines and had "elevated" levels of exposure to their EMFs. The
researchers reported a link between childhood cancer and these elevated exposures.
While the strength of the methodology is questioned today, this study's result, that
elevated exposure to EMFs caused increased death in children from all cancers (with odd
ratios 2-3), has spurred many more groups to study the health effects of ELF EMFs. The
majority of these studies have found no correlation or were inconclusive. 6
3 U.S. Bureau of the Census, Historical Statistics of the United States: Colonial Times to 1970,
Bicentennial Edition, p.827.
4 Ibid.
5 Wetheimer N., Leeper, E. Electrical wiring configuration and childhood cancer. Am J epidemiology
109:227-284 (1979).
6 Ahlbom A, Cardis E et al. Review of the epidemiological literature on EMF and health. Environmental
Health Persp 109:911-933 (2001).
There have also been several occupational hazard studies which looked at workers
exposed to especially strong EMFs. These studies proved equivocal and were too
difficult to conduct because of the rarity of brain cancer, small cohort sizes, and crude
assessment of exposure levels. One study found a significantly increased risk for
gliobastonma multiforme brain cancer.7 It should be noted that there is a danger in
identifying brain cancer from death certificates since often times tumors of the brain are
the result of metastasis from other organs.8
Exposures are typically measured in terms of average magnetic flux density on the order
of microTesla. The background exposure level for populations in their homes is less than
0.3gT but those who live near power lines or have increased exposure through their
occupation can be exposed to levels above 0.8 gT. 9
Characterization of Environmental Factor
In light of the speed with which the incidence of NS cancer increased, one can say that
inherited genetic factors most likely played a negligible causal role, while some
environmental factor caused the change. In characterizing the environmental factor, it is
important to determine whether the risk increased gradually over time or very quickly.
The increased exposure to ELF EMFs was most likely a gradual increase. Furthermore,
the expansion was staggered when considering the differences between urban and rural
populations. In the early 1930s, almost all cities were connected to power grid systems
while only 11% of rural homes were connected, even though the population ratio of
urban-to-rural was 56:44. B 1950, power lines were ubiquitous in both settings and the
population ratio was 60:40.1 Thus, a very significant portion of the population was
decades behind another portion of the population in terms of exposure. If we take power
line EMFs to be the hypothetical risk factor, then for a little over half the population (i.e.
urban) the most significant increase in exposure was between the end of the decade of the
1900s and the early 1930s. For a little less than half the population (i.e. rural), the
supposed environmental risk factor should have increased most dramatically during the
period of the early 1930s until the early 1950s.
7 Ibid.
8 Inskip PD, Linet MS, Heineman EF. Etiology of brain tumors in adults. Epidemiol Rev 17:382-414
(1995).
9 Villeneuve PJ, Agnew DA, et al. Brain cancer and occupational exposure to magnetic fields among men:
results from a Canadian population-based case-control study. International J of Epidemiology 31:210-217
(2002).
10 US Bureau of the Census, http://www.census.gov/population/censusdata/table-4.pdf (1993).
Conclusions
As mentioned earlier, for EAM and EAF, the mortality due to NS cancer shifted with
transition birth cohorts between the 1850s and 1900s. The birth cohorts of the 1900s and
onwards have been consistent, but the changes began for birth cohorts decades before.
Given this, the environmental factor was most likely introduced well before 1900. In
fact, given the changes observed with the birth cohorts, the factor probably started
appearing between 1860-1890. Considering the timing of when power-grid systems were
established, it is reasonable to rule out the possibility that ELF EMFs from power lines
contributed significantly to the shift in NS cancer incidence.
There have been numerous other studies which considered other possible environmental
factors. One popular theory is that smoking cigarettes increases the risk of glioma."
Another possible risk factor includes ionizing radiation.12
" Silvera SA, Miller AB, Rohan TE. Cigarette smoking and the risk of glioma: a prospective cohort study.
Int J of Cancer 118:1848-51 (2006).
12 Savitz D, Trichopoulos D, Brain cancer. In: Adami HO , Hunter D , Trichopoulos D , eds. Textbook of
cancer epidemiology. Oxford: Oxford University Press, 486-503 (2002).
Chapter 3: Physiology and Pathology of Cancer of the Brain
Development of the Central Nervous System
The brain and spinal cord are formed from the neural plate of the early embryo. The NS
develops to consist of around 10" neurons, each of which forms synapses with 103 other
neurons. Placement and connectivity of the neurons, which determine the capabilities of
the NS, are determined during embryonic development. In addition to neurons, there are
about 1012 glial cells. 13 There are three kinds of glial cells: astrocytes, oligodendrocytes,
and microglia. Astrocytes are the most numerous and serve to protect neurons, induce
neurogenesis, regulate synapse formation and synapse transmission and initiate immune
responses. Oligodendrocytes synthesize myelin in the CNS and provide growth factors
for adjacent neurons.
Unlike the cells of most organs, neurons become postmitotic after embryonic
development and have to survive without division throughout the lifespan. Whereas
neurons and oligodendrocytes become postmitotic after differentiation, astrocytes seem to
maintain the potential to proliferate, as evidenced by the gliotic reaction after lesion. 14 In
the brain there are some cells with glial morphology that are now considered neural stem
cells. Radial glial cells are one type of neuronal stem cells and are only present during
development. In the regions of adult neurogenesis, stem cells are found in the
subventricular zone.' 5
Pathology of Glioblastoma and Genetic Risk
Glioblastoma multiforme (GB) is the most common intraparenchymal brain tumor in
adults. Unfortunately it is also the deadliest glioma, which are cancers derived from
glial-like cells. Gliomas comprise 60 percent of CNS malignancies. 16 Specifically, GB is
a kind of astrocytoma, which is a form of glioma. These neoplasts are called
astrocytomas because they possess some morphological characteristics of normal
astrocytes. As mentioned earlier, systemic metastases are rare. However, the tumors are
extremely aggressive in a local fashion, and accordingly GB is nicknamed "whole brain"
or "whole CNS" disease. Histologically and morphologically speaking, glioma formation
resembles closely normal glial differentiation.
Several genetic abnormalities have been found to be associated with gliomas. They
encode for proteins involved in signal transduction, cell growth, cell-cycle
control/proliferation, apoptosis, and differentiation and other critical processes. The
inactivation of the p53 tumor suppressor gene on chromosome 17p has been found to be
13 Slack J.M.W. Essential Developmental Biology. Blackwell Publishing Chapter 14:199-220 (2005).
14 Gotz M., Glial cells generate neurons-master control within CNS regions: Developmental perspectives
on neural stem cells. The Neuroscientist 9(5):379-397 (2003).
15 Slack J.M.W. Essential Developmental Biology. Blackwell Publishing Chapter 14:199-220 (2005).
16 Markert JM. Glioblastoma Multiforme. Jones and Bartlett Publishers Chapters 1-5:1-89 (2005).
associated with progression of GB. 17 Indeed, mutations or deletions18 in p53 are found in
over 50 percent of cancerous tumors. Alterations in the ARF/MDM2/P53 pathway as
well as the INK4/CDK4/RB pathway, which are responsible for cell-cycle machinery,
frequently result in gliomas. Additionally, the over-expression of platelet-driven growth
factor (PDGF) has been shown to be associated with the progression of gliomas to more
malignant tumors. 19 Amplification of the epidermal growth factor receptor (EGF-R) gene
and the expression of angiogenic factors such as vascular endothelial growth factor
(VEGF) have been found to be associated with the progression of tumors to GB. 20
Another growth factor signaling pathway that is frequently altered in gliomas is FGF.2 1
All of these growth factors play important roles in the differentiation process of glial
progenitors, further suggesting similarities between glial differentiation and
malignancies.22
There are two types of GB. The primary, de novo, form is most commonly found in
elderly patients. 80 percent of these cases exhibit an overexpression of EGF-R gene on
chromosome 7p. The average age of diagnosis is 55 years. Meanwhile, secondary GB
afflicts a younger population with a mean age of 40 years. Inactivation of p53 and
overexpression of PDGF ligands and receptors are most commonly associated with the
onset of secondary GB.23
Assessing Historical Environmental Risk Factor
Considering the development of organs, it is possible to mathematically model the
biological processes that ultimately lead to cancer. Armitage and Doll (1954, 1957)
modeled cancer as a two-stage process. The first stage is initiation, where "n" events
occur to create the first preneoplastic cell which grows slowly at the juvenile rate. The
second stage takes place when a preneoplastic cell experiences "m" events which lead to
promotion, after which the neoplastic cell will grow rapidly as a tumor.24,25
Chapter 4 consists of the application of the two-stage model in order to analyze the age-
specific NS cancer rates in the birth cohorts considered in Chapter 1.
17 Sidransky D, Mikkelsen T, et al. Clonal expansion of p53 mutant cells is associated with brain tumor
progression. Nature 355:846-847 (1992).
18 Tyner SD, Venkatachalam S, et al. p53 mutant mice that display early ageing-associated phenotypes.
Nature 415(6867):45-53 (2002).
19 Dunn I.F., et al. Growth factors in glioma angiogenesis: FGFs, PDGFs, EGF, and TGFs. J of Neuro-
Oncol 50:121-137 (2000).20 Ibid.
21 Markert JM.
22 Ibid.
23 Ibid.
24 Armitage P., Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J
Cancer 8:1-12 (1954).25 Armitage P., Doll R. A two-stage theory of carcinogenesis in relation to the age distribution of human
cancer. Br J Cancer 9:161-169 (1957).
Chapter 4: Advanced Analyses
The biological processes by which cancers actually form are not fully understood. It is
therefore difficult and illuminating to attempt to mathematically model cancer. As
mentioned in Chapter 3, Armitage and Doll (1954) were among the first to do so,
modeling cancers as arising from an adult cell population that is constant in number. By
1957, Armitage and Doll proposed the two stage model described in the previous chapter.
In 1981, Moolgavkar and Knudson added to the two stage model the terms necessary to
account for random division and death of preneoplastic cells. 26 Herrero-Jimenez et al.
(2000) have added to the model to account for human heterogeneity and demonstrated its
application on public records on colon cancer in the US.27 By using their model, we can
calculate an estimate for the fraction of the population for a given birth-cohort at primary
risk F for dying of NS cancer.
Several parameters need to be defined. As mentioned earlier, "n" represents the number
of events required for initiation while "m" represents the number of events required for
promotion. Observations of the number and distribution of colonies carrying point
mutation in the lungs have lead Gostjeva and Thilly (2005) to argue that point
mutagenesis is limited to the fetal-juvenile period and that tumor initiation only happens
during this period (up to 17.5 years old on average). 28 The cell proliferation rate is
defined as a cell divisions per year and the cell death rate is defined as P cell deaths per
year. Thus the net cell growth rate per year is a - P. Other parameters include the
initiation and promotion rates per year, cinit and cprom respectively. In order to account for
the deaths by causes connected to primary risk, the parameterf is included as well.
We have applied this model to the birth-cohort of the 1920s to find a best-fit curve to the
OBS(h,t) per 100,000 versus age curve. From these fits we can extract a value of F. We
the range of F at 0.01 to 1.0, meaning we would test values between 1 and 100 percent of
the population at primary risk. We set the range off as 0.05-1.0, because we are unsure
how many deaths were caused by something connected to the primary risk factor. The
range for init was set to 0.1-10.0 since this is on the calculated order. We know less
about the value of cprom but we know it is rare, thus the range was set to 10e-10 to 10e-6.
p is set to zero since the cells rarely die. a has a range (and therefore, so does a - P) of
0.1 to 0.3, which is based on observationally based estimates. We set n = 2 and m =1 as a
trial. We then have 10 iterations for each of the five parameters done over each one's
range, yielding a total of 105 iterations of fitting curves.
26 Moolgavkar SH, Knudson AG. Mutation and cancer: a model for human carcinogenesis. JNCI
66(6):1037-1052 (1981).
27 Herrero-Jimenez P, et al. Population risk and physiological rate parameters for colon cancer. The union
of an explicit model for carcinogenesis with the public health records of the United States. Mut Res
Frontiers 447:73-116 (2000).
28 Gostjeva EV, Thilly WG. Stem cell stages and the origins of colon cancer: a multidisciplinary
perspective. Stem Cell Rev 1:243-251 (2005).
An example of one of the top ten (i.e. best-fit) of these 100,000 curves is presented in
Figure 3 below.
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Figure 3: OBS(h,t) per 100,000 versus age at death for EAM 1920s birth cohort.
The green data set represents the actual data from pubic records; the yellow data
set represents the best-fit curve based on our multiparameter model.
The model curve is based on the following parameter values: a = 0.122, f= 0.78, cinit =
7
.
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, cprom = 7.77e-6, and F = 0.01. If the model were applied to birth-cohorts starting
from the 1900s and onward, the fraction at risk would also most likely be the same,
indicating that whatever the environmental factor was, it appeared before 1900 and did
not change in the past century, which corroborates our ruling out the possibility of power-
line EMFs being a factor. Our model assumes that a supposed environmental factor
would either increase the number of persons initiated during the fetal-juvenile period, or
the number of persons in whom promotion occurs in adult life.
Looking back to Figure 1, we can see that there is no consistency in the curves prior to
the birth-cohorts of 1890s and 1900s. It is therefore difficult to pin down when precisely
the environmental factor started to play a significant role in NS cancer incidence.
Additionally this makes it difficult to deduce whether the environmental factor acts on
the fetal-juvenile period or adult life. Mutation rates derived from the model can serve as
an estimate for how many mutations occur, and thus, which genes could be losing their
heterozygosity. Further improvement of the model will continue to help elucidate the
connections between mutagenesis, cellular kinetics, cancer research and
macroepidemiology.
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